SEC Form 4 · accession 0001628280-26-043002
Pacira BioSciences, Inc. · PCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Laura Brege
Director
Period of report
Jun 10, 2026
Accepted (ET)
Jun 12, 2026 · 9:06 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001396814
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 10, 2026 | A | 6,405 | $0.00 | A | 30,120 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $23.42 | Jun 10, 2026 | A | 10,891 | A | Jun 10, 2027 | Jun 10, 2036 | Common Stock | 10,891 | 10,891 | D |
Explanation of responses
- F1Represents restricted stock units that vest on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
- F2The stock option vests and becomes exercisable on June 10, 2027, provided that the reporting person remains in continuous service with the issuer through the vesting date.